Investigational Site Number :3480007

Budapest 1213

0 studies enrolling now · 7 studies all time

What they study most

Asthma, Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP), Chronic Rhinosinusitis With Nasal Polyps, Non-relapsing Secondary Progressive Multiple Sclerosis, Non-small Cell Lung Cancer Metastatic, Progressive Relapsing Multiple Sclerosis, Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients — Stopped early
• Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma — Completed
• A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. — Running, not enrolling
• EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients — Completed
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed
• A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus — Completed
• A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps — Completed